Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
Zeynep Alkin,1 Irfan Perente,1 Abdullah Ozkaya,1 Dilek Alp,1 Alper Agca,1 Ebru Demet Aygit,1 Selcuk Korkmaz,2 Ahmet Taylan Yazici,1 Ahmet Demirok1 1Beyoglu Eye Training and Research Hospital, Istanbul, Turkey; 2Hacettepe University Faculty of Science, Department of Statistics, Ankara, Turkey Purpo...
Enregistré dans:
Auteurs principaux: | Alkin Z, Perente I, Ozkaya A, Alp D, Agca A, Aygit ED, Korkmaz S, Yazici AT, Demirok A |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/1bd4be43b9c54b0a832b38d55ddb99d0 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
par: Sanguansak T, et autres
Publié: (2015) -
3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization
par: Yu-Chen Hu, et autres
Publié: (2021) -
Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy
par: Ratanasukon M, et autres
Publié: (2013) -
Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy
par: Dhirani NA, et autres
Publié: (2017) -
Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
par: Fujita K, et autres
Publié: (2012)